Loma Linda, CA, United States of America

Karen Hay

This inventor holds 1 USPTO granted patent. Top assignee: Loma Linda University. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Hemostatic Analysis by Karen Hay

Introduction

Karen Hay is an accomplished inventor based in Loma Linda, California. She has made significant contributions to the field of hemostatic analysis, focusing on the assessment of platelet function and coagulation status. Her work is vital for improving patient care and outcomes in medical settings.

Latest Patents

Karen Hay holds a patent for "Systems and methods for hemostatic analysis." This invention provides systems and methods for analyzing a whole blood sample from an individual to determine their platelet function and coagulation status in a substantially automated and efficient manner. The patent also includes systems, reagent kits, and methods for the concurrent assessment of platelet function and coagulation as they interact during hemostasis. She has 1 patent to her name.

Career Highlights

Karen is affiliated with Loma Linda University, where she continues to advance her research and innovations in the medical field. Her work has the potential to transform how hemostatic analysis is conducted, leading to better diagnostic tools and treatment options.

Collaborations

Throughout her career, Karen has collaborated with notable colleagues, including Brian S. Bull and John F. Wetteland. These partnerships have enriched her research and contributed to the development of her innovative solutions.

Conclusion

Karen Hay's contributions to hemostatic analysis exemplify the impact of innovation in healthcare. Her dedication to improving patient outcomes through advanced technology is commendable and highlights the importance of continued research in this critical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…